Filter
142
Text search:
OPAS
Featured
Recommendations
15
New Publications
13
Language
Document type
Guidelines
69
No document type
27
Studies & Reports
15
Manuals
14
Strategic & Response Plan
6
Fact sheets
6
Training Material
2
Brochures
1
Situation Updates
1
Resource Platforms
1
Countries / Regions
Brazil
89
Mozambique
25
Angola
19
Latin America and the Carribbean
18
Guinea-Bissau
9
Paraguay
3
Congo, Democratic Republic of
1
Uganda
1
Nepal
1
Germany
1
Thailand
1
Malawi
1
Global
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
89
Clinical Guidelines
8
Public Health
6
Pharmacy & Technologies
5
Women & Child Health
3
Key Resources
2
Capacity Building
1
Toolboxes
COVID-19
87
HIV
7
Rapid Response
5
TB
4
Disability
3
Zika
3
Mental Health
3
Natural Hazards
2
Refugee
2
Planetary Health
2
NTDs
2
Ebola
1
Conflict
1
Pharmacy
1
Quem deve usar este documento
Esta lista de verificação destina-se a supervisores que apoiam os encarregados de realizar a vacinação contra a COVID-19.
Quando usar este documento
Use este documento para se preparar e conduzir
visitas de supervisão, presenciais ou remotas.
Technical specifications for selection of essential in vitro diagnostic tests for SARS-COV-2, 14 June 2021
Hypertension and COVID-19: Scientific report - 17 June 2021
Facilitator's Manual - Inter-action Review on the response to COVID-19 - 28 April 2021
Guidance for clinical case management of thrombosis syndrome with thrombocytopenia (TTS) following vaccination to prevent coronavirus disease (COVID-19)
Interim guidance 19 July 2021
Interim recommendations for the use of ChAdOx1-S [recombinant] COVID-19 vaccine (AstraZeneca COVID-19 AZD1222 Vaxzevria™, SII COVISHIELD™ vaccine) - Last updated 30 July 2021
Resumo: o que é esta orientação dinâmica?
Pergunta clínica: qual é o papel dos medicamentos na prevenção da COVID-19?
Público-alvo: o público-alvo são os médicos e os tomadores de decisão na área da saúde.
Prática atual: o uso atual de medicamentos para prevenção da COVID-19 é
...
O SAGE aplica os princípios da medicina baseada em evidências e estabeleceu um processo metodológico completo para emitir ou atualizar recomendações. Especificamente para vacinas contra a COVID-19, uma descrição detalhada dos processos metodológicos pode ser encontrada no esquema de evidênc
...
Strengthening surveillance for Variant of Concern (VOC) Omicron (B.1.1.529): technical brief and priority actions for member states World Health Organization Headquarters, 28 November 2021
WHO lists 9th COVID-19 vaccine for emergency use to expand vaccination access in low-income countries, 17 December 2021
TECHNICAL SPECIFICATIONS FOR TEST SELECTION ESSENTIAL IN VITRO DIAGNOSTIC TESTS FOR SARS-COV-2
Critical preparedness, readiness and response actions for COVID-19
Interim Guidance - 27 May 2021
WHO Information Leaflet COVID-19: Considerations on tuberculosis (TB) care
Evaluation of the effectiveness of vaccines against COVID-19
INTERIM GUIDANCE 17 MARCH 2021
Definition and categorization of the time of vertical transmission of SARS-CoV-2
Scientific report 8 February 2021
Acessed on 12.05.2022
Considerations on the implementation and adjustment of
public health and social measures in the context of
COVID-19
Interim guidance 14 June 2021
Checklist for risk and impact management of pandemics of COVID-19
Este documento incluye los resultados de un proceso de elaboración rápida de guías. La información incluida en esta guía refleja la evidencia a la fecha publicada en el documento. Las recomendaciones se basaron en la evidencia disponible y su calidad (metodología GRADE) en el momento en que s
...
Accessed on 21.05.2022
